Literature DB >> 19737153

CTLA4 exon 1 and promoter polymorphisms in patients with multiple sclerosis.

G Yousefipour1, N Erfani, M Momtahan, H Moghaddasi, A Ghaderi.   

Abstract

OBJECTIVE: The polymorphisms of exon 1 (+49 A/G) and promoter regions (-1722 T/C, -1661 A/G and -318 C/T)of cytotoxic T lymphocyte antigen 4 (CTLA4) and also haplotypes constructed from mentioned loci were investigated amongst 153 Iranian patients with definite multiple sclerosis (MS) and 190 healthy controls.
METHODS: The polymorphisms were genotyped by PCR-restriction fragment length polymorphisms and PCR-amplification refractory mutation system. The 4-locus haplotypes were estimated by Arlequin software (University of Berne, Berne, Switzerland).
RESULTS: Preliminary results showed significant increase of +49 G allele and -1661 AG genotype, as well as TGCA haplotype among patients than controls (P < 0.036, P = 0.009 and P < 0.010, respectively). The distribution of -1722 T/C, -1661 A/G, -318 C/T and +49 A/G (TACA) haplotype, from the contrary, was observed to be significantly increased among controls (P < 0.001).
CONCLUSIONS: After Bonferroni correction, the results provide preliminary evidence that CTLA4 genetic variation at -1661 locus may render Iranian individuals to be more susceptible to MS, whereas harboring TACA haplotype might be protective.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19737153     DOI: 10.1111/j.1600-0404.2009.01177.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  9 in total

1.  Interaction between CTLA4 gene and IBD5 locus in Hungarian Crohn's disease patients.

Authors:  Veronika Csöngei; Luca Járomi; Eniko Sáfrány; Csilla Sipeky; Lili Magyari; Noémi Polgár; Judit Bene; Patrícia Sarlós; Lilla Lakner; Eszter Baricza; Melinda Szabó; Gábor Rappai; Béla Melegh
Journal:  Int J Colorectal Dis       Date:  2011-04-26       Impact factor: 2.571

Review 2.  Genetic and Molecular Biology of Multiple Sclerosis Among Iranian Patients: An Overview.

Authors:  Meysam Moghbeli
Journal:  Cell Mol Neurobiol       Date:  2019-09-03       Impact factor: 5.046

3.  Correlation of -475 IL-2 Promoter Gene Polymorphisms and the Levels of Serum IL-2 on the Risk of Multiple Sclerosis.

Authors:  Thekra Abdulaali Abed; Anwar Ali Abdulla
Journal:  Rep Biochem Mol Biol       Date:  2022-04

4.  Correlation between CTLA-4 gene rs221775A>G single nucleotide polymorphism and multiple sclerosis susceptibility. A meta-analysis.

Authors:  Xiao Haibing; Cao Xu; Cai Jifu; Zeng Wenshuang; Li Ling; Cui Yuzhen; Hu Yanjun
Journal:  Open Med (Wars)       Date:  2016-07-22

5.  The Association Between Viral Infections and Co-stimulatory Gene Polymorphisms in Kidney Transplant Outcomes.

Authors:  Ahmad Niknam; Mohammad Hossein Karimi; Ramin Yaghobi; Bita Geramizadeh; Jamshid Roozbeh; Mehdi Salehipour; Mahdiyar Iravani
Journal:  Jundishapur J Microbiol       Date:  2016-02-17       Impact factor: 0.747

Review 6.  The Role of Cytotoxic T-Lymphocyte Antigen 4 in the Pathogenesis of Multiple Sclerosis.

Authors:  Maria Sofia Basile; Placido Bramanti; Emanuela Mazzon
Journal:  Genes (Basel)       Date:  2022-07-24       Impact factor: 4.141

7.  Investigation of the association between the genetic polymorphisms of the co-stimulatory system and systemic lupus erythematosus.

Authors:  Ding-Ping Chen; Wei-Tzu Lin; Kuang-Hui Yu
Journal:  Front Immunol       Date:  2022-09-06       Impact factor: 8.786

8.  Association of the Co-stimulatory Molecules Polymorphisms with CMV Infection in Liver Transplant Recipients.

Authors:  M H Karimi; M Motazedian; B Geramizadeh; S Nikeghbalian; R Yaghobi; F Abedi; M Hossin Aghdaee; N Azarpira; M Arabpour; Z Malekpour; M Namayandeh
Journal:  Int J Organ Transplant Med       Date:  2011

9.  CTLA-4 polymorphisms and haplotype correlate with survival in ALL after allogeneic stem cell transplantation from related HLA-haplotype-mismatched donor.

Authors:  X-Y Qin; Y Wang; G-X Li; Y-Z Qin; F-R Wang; L-P Xu; H Chen; W Han; J-Z Wang; X-H Zhang; Y-J Chang; K-Y Liu; Z-F Jiang; X-J Huang
Journal:  J Transl Med       Date:  2016-04-27       Impact factor: 5.531

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.